← Leaderboards
David N Herrmann
University Of Rochester
$7,677,030
Attributed
$7,677,030
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,677,030 · 3
By mechanism
U01$6,423,135 · 1
K23$830,395 · 1
R21$423,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsIn VivoSiteCohortNeurologicNeuropathyAffectSensorySeveritiesTouch SensationDensityResearch PersonnelPainlessOutcome MeasureSkinBiopsyBiomarker ValidationAnkleBiological MarkersClinicAdultCritical PathwaysDisability
Grant awards (12)
Accelerate Clinical Trials in CMT (ACTCMT) Study$1,059,590
U01 · FY2023 · NS · contact PI
Accelerate Clinical Trials in CMT (ACTCMT) Study$1,258,621
U01 · FY2022 · NS · contact PI
Accelerate Clinical Trials in CMT (ACTCMT) Study$1,340,296
U01 · FY2021 · NS · contact PI
Accelerate Clinical Trials in CMT (ACTCMT) Study$1,343,853
U01 · FY2020 · NS · contact PI
Accelerate Clinical Trials in CMT (ACTCMT) Study$1,420,775
U01 · FY2019 · NS · contact PI
In-Vivo Confocal Imaging of Meissner's Corpuscles as a Measure of HIV Neuropathy$231,000
R21 · FY2008 · NS · contact PI
In-Vivo Confocal Imaging of Meissner's Corpuscles as a Measure of HIV Neuropathy$192,500
R21 · FY2007 · NS · contact PI
Epidermal Innervation as an Outcome Measure$166,079
K23 · FY2006 · NS · contact PI
Epidermal Innervation as an Outcome Measure$166,079
K23 · FY2005 · NS
Epidermal Innervation as an Outcome Measure$166,079
K23 · FY2004 · NS
Epidermal Innervation as an Outcome Measure$166,079
K23 · FY2003 · NS
Epidermal Innervation as an Outcome Measure$166,079
K23 · FY2002 · NS